A study shows that a molecule produced by intestinal microbes can enter the brain and that its presence is also associated with altered brain connectivity.

Meet some of the people featured in the August 2011 issue of The Scientist.

The gut microbiome has been linked to depression, schizophrenia, and other neurological conditions, but it’s not yet clear whether the relationship is causal.

Our list of the best and brightest products that 2011 had to offer the life scientist

Putting Polio to Good Use Add polio to a host of other viral and bacterial foes that, in modified forms, could prove therapeutically beneficial. Although Russian scientists attempted to use polio to treat cancer in the 1960s--unpublished experiments about which little is known--a recent brain cancer study in mice is the first modern-day attempt to harness the power of the virus (M. Gromeier et al., "Intergeneric poliovirus recombinants for the treatment of malignant glioma," Proceedings of the

Author: SIMON SILVER Department of Microbiology & Immunology University of Illinois Chicago The Luddites have mostly won during the 15 years of recombinant DNA research and debates. An FDA report concludes that bovine growth hormone presents no increased health risk. Yet the combination of building political bases and mounting irrational fear of genetic engineering means that we will probably continue to be protected from this unreal danger. Our students have questioning minds, so this compilat

Ever had the urge to take a nice crunchy bite of Drosophila or lick icing off a brain? You will after a visit to linkurl:Not So Humble Pie,;http://notsohumblepie.blogspot.com/ a blog run by scientist-turned-baker, Ms. Humble. A blogger who refers to herself as "a typical nerdy biological anthropologist turned stay at home mom," Ms. Humble -- who chooses to remain anonymous -- began the blog in October 2009. Since then, the popular blog has regularly featured science-themed baked goods, from zebr

Meet some of the people featured in the May 2017 issue of The Scientist.

The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.

African trypanosomiasis is making an unwelcome comeback. But unlike other returning diseases, this one has a drug treatment—eflornithine—that disappeared from the market when it failed to cure cancer. Yet like Viagra's origin from a curious side effect in a clinical trial, so too was eflornithine reborn. "When it was discovered that it removes mustaches in women, it suddenly had a market: western women with mustaches," says Morten Rostrup, president of the international council for M